Chr Hansen A/S
9
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
11.1%
1 terminated/withdrawn out of 9 trials
88.9%
+2.4% vs industry average
44%
4 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
The Effects of Bifidobacterium Breve Bif195 for Small Intestinal Crohn's Disease
Role: collaborator
Effect of Probiotics in Reducing Infections and Allergies in Young Children Starting Daycare
Role: collaborator
Effect of Probiotics on Health-related Quality of Life in College Students With Upper Respiratory Infections
Role: collaborator
Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis
Role: collaborator
Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier
Role: collaborator
The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
Role: collaborator
Effect Of Probiotic Lactobacillus Paracasei Lp-33 For The Management Of Rhinitis In People Sensitized To Allergens
Role: collaborator
ProSat - Effect of Probiotics on Satiety
Role: collaborator
The Effect of Probiotics on Infections in Toddlers
Role: collaborator
All 9 trials loaded